The “2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome” retires, replaces, and expands upon the “2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults.” The primary intended audience for this guideline is clinicians who care for patients across the spectrum of cardiovascular-kidney-metabolic…
This collection provides an abridged version of the American Diabetes Association’s (ADA’s) Standards of Care in Diabetes—2026 designed especially for primary care professionals. Developed by the ADA’s Primary Care Advisory Group*, this new resource contains the evidence-based clinical practice recommendations most pertinent to primary care—all presented in a user-friendly format.…
This guideline establishes clinical practice recommendations for combination treatment of chronic insomnia disorder in adults, defined here as treatment with cognitive-behavioral therapy for insomnia (CBT-I) started concurrently with pharmacotherapy.
Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos. The objective of this guideline from a Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) panel is to expand on current cardiovascular guidelines to include evidence from…
Since 1940, the American Diabetes Association® has been a trusted source for cutting-edge diabetes care education solutions. Our Institute of Learning offers 70+ free continuing education courses, webinars, and more to help you stay ahead of the curve.
The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in evidence. This updated guideline is intended to provide a comprehensive, up-to-date, evidence-based set of recommendations, advising management from…
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released the 2026 updated version of its Global Strategy for Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease.
Obesity as a global public health issue is a relatively recent but growing problem for all countries. Obesity arises from a set of complex interactions in individuals including genetics, neurobiology, and eating behaviors, as well as obesogenic environments resulting from shifts in diet, activity, and lifestyle alongside globalization and industrialization…
Prescribing cascades are an underrecognized driver of polypharmacy among older adults (aged ≥65 years). The clinical decision-making processes underlying cascades and their downstream consequences are poorly understood. This small study shows how providers may believe they are treating edema or heart failure – when it could be ongoing Gabapentinoid-Diuretic Prescribing…